Designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge and resources to translate their research into new drugs to treat and prevent neurodegenerative diseases.

Attendees from academia and industry will also learn from specific case studies examples and have an opportunity to engage in interactive discussions on securing partnerships.

It focuses on Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis.